Buying More of This Small-Cap Name as Shares Fall Under Pressure
We’re also looking to take some profit after a $6.9 million update boosted another name.
We’re also looking to take some profit after a $6.9 million update boosted another name.
Most investors treat earnings reactions like a bet at the casino. Here’s the smarter approach.
The automaker enjoyed a strong report and I’ve got a lucrative trade idea.
After Travelers’ blowout quarter, will other big names follow suit?
Earnings this week from Alphabet, Texas Instruments, Intel and others may lead to a few ratings changes.
The Big Tech giant had its worst losses in more than a century but the bottom might be in.
A classic Monday morning bull trap has snapped, and selling pressure is ramping up again.
There can’t be much upside left.
Here’s the latest on our Ocular Therapeutix trading strategy, a planned purchase for today and some additional portfolio news.
One is in an oversold condition, while the other’s prospects for higher production levels improve.